目的探讨血必净注射液联合氯解磷定注射液治疗有机磷农药中毒的临床疗效。方法选取2012年3月—2016年3月商丘市第一人民医院收治的有机磷农药中毒患者82例,根据治疗方案的不同分为对照组(36例)和治疗组(46例)。对照组足量应用氯解磷定...目的探讨血必净注射液联合氯解磷定注射液治疗有机磷农药中毒的临床疗效。方法选取2012年3月—2016年3月商丘市第一人民医院收治的有机磷农药中毒患者82例,根据治疗方案的不同分为对照组(36例)和治疗组(46例)。对照组足量应用氯解磷定注射液,用药间隔时间为2~4 h,在胆碱酯酶活力≥60%正常值后停药。治疗组在对照组的基础上静脉滴注血必净注射液,50 m L加入生理盐水100 m L,1次/d。两组患者均持续治疗7 d。观察记录两组患者存活情况、中间综合征和胆碱酯酶恢复时间及肌酸激酶同工酶(CK-MB)和肌钙蛋白T(CTn T)变化。结果治疗后,治疗组死亡病例存活时间显著长于对照组,住院时间显著短于对照组,两组比较差异具有统计学意义(P<0.05)。治疗后,治疗组中间综合征发生率和胆碱酯酶恢复正常时间均显著低于对照组,两组比较差异具有统计学意义。治疗后,两组患者CK-MB和CTn T均显著降低,同组比较差异具有统计学意义(P<0.05);且治疗组患者CK-MB和CTn T比对照组更低,两组比较差异具有统计学意义(P<0.05)。结论血必净注射液联合氯解磷定注射液治疗有机磷农药中毒可降低中间综合征发生率和胆碱酯酶恢复正常时间,具有更好的心肌保护作用,具有一定的临床推广应用价值。展开更多
BACKGROUND:Penehyclidine is a newly developed anticholinergic agent.We aimed to investigate the role of penehyclidine in acute organophosphorus pesticide poisoning(OP)patients.METHODS:We searched the Pubmed,Cochrane l...BACKGROUND:Penehyclidine is a newly developed anticholinergic agent.We aimed to investigate the role of penehyclidine in acute organophosphorus pesticide poisoning(OP)patients.METHODS:We searched the Pubmed,Cochrane library,EMBASE,Chinese National Knowledge Infrastructure(CNKI),Chinese Biomedical literature(CBM)and Wanfang databases.Randomized controlled trials(RCTs)recruiting acute OP patients were identifi ed for meta-analysis.Main outcomes included cure rate,mortality rate,time to atropinization,time to 60%normal acetylcholinesterase(AchE)level,rate of intermediate syndrome(IMS)and rate of adverse drug reactions(ADR).RESULTS:Sixteen RCTs involving 1,334 patients were identifi ed.Compared with the atropineor penehyclidine-alone groups,atropine combined with penehyclidine significantly increased the cure rate(penehyclidine+atropine vs.atropine,0.97 vs.0.86,RR 1.13,95%CI[1.07–1.19];penehyclidine+atropine vs.penehyclidine,0.93 vs.0.80,RR 1.08,95%CI[1.01–1.15])and reduced the mortality rate(penehyclidine+atropine vs.atropine,0.015 vs.0.11,RR 0.17,95%CI[0.06–0.49];penehyclidine+atropine vs.penehyclidine,0.13 vs.0.08,RR 0.23,95%CI[0.04–1.28]).Atropine combined with penehyclidine in OP patients also helped reduce the time to atropinization and AchE recovery,the rate of IMS and the rate of ADR.Compared with a single dose of atropine,a single dose of penehyclidine also signifi cantly elevated the cure rate,reduced times to atropinization,AchE recovery,and rate of IMS.CONCLUSION:Atropine combined with penehyclidine benefi ts OP patients by enhancing the cure rate,mortality rate,time to atropinization,AchE recovery,IMS rate,total ADR and duration of hospitalization.Penehyclidine combined with atropine is likely a better initial therapy for OP patients than atropine alone.展开更多
文摘目的探讨血必净注射液联合氯解磷定注射液治疗有机磷农药中毒的临床疗效。方法选取2012年3月—2016年3月商丘市第一人民医院收治的有机磷农药中毒患者82例,根据治疗方案的不同分为对照组(36例)和治疗组(46例)。对照组足量应用氯解磷定注射液,用药间隔时间为2~4 h,在胆碱酯酶活力≥60%正常值后停药。治疗组在对照组的基础上静脉滴注血必净注射液,50 m L加入生理盐水100 m L,1次/d。两组患者均持续治疗7 d。观察记录两组患者存活情况、中间综合征和胆碱酯酶恢复时间及肌酸激酶同工酶(CK-MB)和肌钙蛋白T(CTn T)变化。结果治疗后,治疗组死亡病例存活时间显著长于对照组,住院时间显著短于对照组,两组比较差异具有统计学意义(P<0.05)。治疗后,治疗组中间综合征发生率和胆碱酯酶恢复正常时间均显著低于对照组,两组比较差异具有统计学意义。治疗后,两组患者CK-MB和CTn T均显著降低,同组比较差异具有统计学意义(P<0.05);且治疗组患者CK-MB和CTn T比对照组更低,两组比较差异具有统计学意义(P<0.05)。结论血必净注射液联合氯解磷定注射液治疗有机磷农药中毒可降低中间综合征发生率和胆碱酯酶恢复正常时间,具有更好的心肌保护作用,具有一定的临床推广应用价值。
文摘BACKGROUND:Penehyclidine is a newly developed anticholinergic agent.We aimed to investigate the role of penehyclidine in acute organophosphorus pesticide poisoning(OP)patients.METHODS:We searched the Pubmed,Cochrane library,EMBASE,Chinese National Knowledge Infrastructure(CNKI),Chinese Biomedical literature(CBM)and Wanfang databases.Randomized controlled trials(RCTs)recruiting acute OP patients were identifi ed for meta-analysis.Main outcomes included cure rate,mortality rate,time to atropinization,time to 60%normal acetylcholinesterase(AchE)level,rate of intermediate syndrome(IMS)and rate of adverse drug reactions(ADR).RESULTS:Sixteen RCTs involving 1,334 patients were identifi ed.Compared with the atropineor penehyclidine-alone groups,atropine combined with penehyclidine significantly increased the cure rate(penehyclidine+atropine vs.atropine,0.97 vs.0.86,RR 1.13,95%CI[1.07–1.19];penehyclidine+atropine vs.penehyclidine,0.93 vs.0.80,RR 1.08,95%CI[1.01–1.15])and reduced the mortality rate(penehyclidine+atropine vs.atropine,0.015 vs.0.11,RR 0.17,95%CI[0.06–0.49];penehyclidine+atropine vs.penehyclidine,0.13 vs.0.08,RR 0.23,95%CI[0.04–1.28]).Atropine combined with penehyclidine in OP patients also helped reduce the time to atropinization and AchE recovery,the rate of IMS and the rate of ADR.Compared with a single dose of atropine,a single dose of penehyclidine also signifi cantly elevated the cure rate,reduced times to atropinization,AchE recovery,and rate of IMS.CONCLUSION:Atropine combined with penehyclidine benefi ts OP patients by enhancing the cure rate,mortality rate,time to atropinization,AchE recovery,IMS rate,total ADR and duration of hospitalization.Penehyclidine combined with atropine is likely a better initial therapy for OP patients than atropine alone.
